Financial Performance - The company reported a cash dividend of 3.44 RMB per 10 shares for all shareholders, based on a total of 229,619,667 shares[3]. - The company's operating revenue for 2022 was ¥4,842,783,545.67, representing a 40.59% increase compared to ¥3,444,636,127.78 in 2021[19]. - The net profit attributable to shareholders for 2022 was ¥525,718,826.08, a 25.89% increase from ¥417,594,673.31 in 2021[19]. - The net cash flow from operating activities reached ¥513,847,807.57, marking a significant increase of 64.63% from ¥312,125,695.41 in 2021[19]. - The total assets at the end of 2022 amounted to ¥7,582,823,208.24, a 35.95% increase from ¥5,577,662,386.18 at the end of 2021[19]. - The company achieved a compound annual growth rate (CAGR) of 27.52% in sales revenue from 2011 to 2022[31]. - The compound annual growth rate (CAGR) for net profit attributable to shareholders from 2011 to 2022 was 31.47%[31]. - The company reported a basic earnings per share of ¥2.3965 for 2022, up 17.65% from ¥2.0369 in 2021[19]. - The company achieved a revenue of 4.843 billion yuan in 2022, representing a year-on-year growth of 40.59%[74]. - The net profit attributable to shareholders was 526 million yuan, an increase of 25.89% compared to the previous year[74]. Market Expansion and Strategy - The company aims to expand its market presence and enhance its supply chain management capabilities[10]. - The company is focused on developing new products and technologies in the polymer materials sector, particularly in chemical additives[11]. - The company aims to be a global leader in polymer material anti-aging technology, which is essential for extending the lifespan of materials and reducing carbon emissions[32]. - The company plans to increase its market presence in the rapidly growing China and Asia-Pacific markets, as well as in the Middle East, Eastern Europe, Africa, and South America[74]. - The company is actively pursuing new technologies and product developments to maintain its market position and drive future growth[55]. - The company is committed to breaking the foreign monopoly in the gas engine oil market, which is currently dominated by Chevron[103]. - The company is focusing on expanding its market presence through strategic partnerships and potential acquisitions in the chemical sector[137]. Research and Development - The company has established a life sciences division, focusing on two key areas: biological building blocks and synthetic biology, aiming to create internationally leading technologies and products[46]. - The company has built a research and operation team of about 50 people in the life sciences sector, with several new products expected to enter trial production soon[49]. - The company has developed multiple patented production technologies for antioxidants, including RIANOXMD-1024 and RIANOX1010, with several patents filed under ZL and CN numbers[52]. - The company is actively pursuing the industrialization of nucleic acid drug monomers and technologies, positioning itself for future growth in the pharmaceutical sector[48]. - The company is focusing on new material technology research and development, aiming to enhance its product offerings and market competitiveness[137]. - The company has a research team of over 300 people and is collaborating with top universities to innovate in polymer materials and life sciences[148]. Acquisitions and Partnerships - The company completed the acquisition of Jinzhou Kangtai, adding lubricating oil additives to its main business, which is expected to drive sustained high growth[39]. - The company has integrated Jinzhou Kangtai into its system as a subsidiary since May 2022, focusing on achieving expected synergies and operational integration[159]. - The company invested in Jinzhou Kangtai Lubricant Additive Co., Ltd. through share issuance and cash payment, aiming to expand market supply and customer assurance capabilities in the lubricant additive sector[140]. - The establishment of the "Lubricating Oil Industry Innovation Alliance" aims to address the self-controllable supply chain challenges in China's lubricating oil sector, with significant strategic opportunities expected from the upcoming release of diesel and gasoline engine lubricating oil standards[44]. Environmental and Safety Management - The company has a comprehensive EHS management system to improve safety, environmental, and health performance[10]. - The company is committed to green development, aligning with carbon neutrality policies and investing in energy-saving technologies[81]. - The company has a strong emphasis on environmental protection through the development of high-efficiency and eco-friendly antioxidant products[52]. - The company is committed to contributing to carbon neutrality goals through innovative recycling solutions[101]. Governance and Management - The company has a governance structure in place with a board of directors and supervisory board, ensuring compliance with corporate governance standards[192]. - The company has established a transparent performance evaluation and incentive mechanism for senior management[180]. - The company has a diverse board composition, including independent directors, to ensure a balanced decision-making process[192]. - The company has maintained a stable shareholding structure, with no significant changes in the number of shares held by directors and senior management during the reporting period[192]. - The company respects and protects the legitimate rights and interests of stakeholders, balancing the interests of customers, employees, shareholders, and society[181]. Financial Management - The company has implemented measures to manage accounts receivable risks, including performance assessments for marketing personnel and credit control based on customer classification[158]. - The company is committed to enhancing financial and internal control management post-acquisition to mitigate risks[159]. - The company reported a significant increase in cash received from investment to CNY 423.90 million in 2022 from CNY 3 million in 2021[104]. - The company has ongoing research and development efforts in new materials, with a focus on expanding its product offerings in the chemical sector[115]. Future Outlook - The company plans to launch three new products in 2023, targeting a market expansion of 20% in the new segments[166]. - Future guidance estimates a revenue growth of 10-15% for 2023, driven by new product launches and market expansion efforts[165]. - The company is exploring potential acquisitions to enhance its product portfolio and market reach, with a budget of 500 million RMB allocated for this purpose[173]. - The company aims to enhance its product offerings in response to stricter emission regulations and the decreasing availability of fossil resources[102].

Financial Performance - The company's operating revenue for 2022 was ¥4,842,783,545.67, representing a 40.59% increase compared to ¥3,444,636,127.78 in 2021[19]. - The net profit attributable to shareholders for 2022 was ¥525,718,826.08, a 25.89% increase from ¥417,594,673.31 in 2021[19]. - The net cash flow from operating activities reached ¥513,847,807.57, marking a significant increase of 64.63% from ¥312,125,695.41 in 2021[19]. - The total assets at the end of 2022 amounted to ¥7,582,823,208.24, a 35.95% increase from ¥5,577,662,386.18 at the end of 2021[19]. - The company achieved a compound annual growth rate (CAGR) of 27.52% in sales revenue from 2011 to 2022[31]. - The compound annual growth rate (CAGR) for net profit attributable to shareholders from 2011 to 2022 was 31.47%[31]. - The company reported a basic earnings per share of ¥2.3965 for 2022, reflecting a 17.65% increase from ¥2.0369 in 2021[19]. - The company achieved a revenue of 4.843 billion yuan in 2022, representing a year-on-year growth of 40.59%[74]. - The net profit attributable to shareholders was 526 million yuan, an increase of 25.89% compared to the previous year[74]. Market Expansion and Strategy - The company aims to enhance its market presence through new product development and technological advancements in polymer materials[11]. - The company is focused on expanding its user base and improving customer engagement through innovative solutions in chemical additives[11]. - The company is exploring potential mergers and acquisitions to accelerate growth and enhance its competitive edge in the market[11]. - The company has set ambitious performance targets for the upcoming fiscal year, aiming for a significant increase in revenue and market share[11]. - The company is actively investing in research and development to innovate and improve its product offerings in the high polymer materials sector[11]. - The company is strategically positioned to leverage its technological advancements and production capabilities to capture a larger market share in the chemical industry[53]. - The company is expanding its market presence in high-growth regions such as China, the Asia-Pacific, the Middle East, Eastern Europe, Africa, and South America[74]. - The company plans to continue expanding its market presence and product offerings, particularly in the lubricant additives sector[94]. - The company aims to enhance its supply assurance capabilities and establish a leading position in the global industry[140]. Research and Development - The company is committed to maintaining a robust pipeline of new product developments and technological advancements in the antioxidant sector[52]. - The company has developed multiple patented production technologies for antioxidants, including RIANOXMD-1024 and RIANOX1010, with several patents filed under ZL201010514830.8 and ZL201310373588.0[52]. - The company has established a life sciences division, focusing on two key areas: biological building blocks and synthetic biology, aiming to develop internationally competitive technologies and products[46]. - The company has built a research and operation team of about 50 people in the life sciences sector, with plans for new products to be trial-produced and launched soon[49]. - The company is focused on the innovation of high-performance UV stabilizers, with several patented technologies for products like UV-326 and UV-360[52]. - The company is actively developing new technologies and products, including a boron-based dispersant and various antioxidant formulations for lubricants[53]. - The company has a strong focus on R&D, with multiple patents filed for new materials and production processes, enhancing its competitive edge in the market[53]. - The R&D team consists of over 300 members, with new research institutes established to enhance innovation in polymer materials and life sciences[147]. Environmental and Social Responsibility - The company emphasizes its commitment to environmental and social responsibility in its operational strategies[11]. - The company has a strong focus on environmental protection in its production processes, as evidenced by its development of eco-friendly technologies[52]. - The company has committed to green development in response to carbon neutrality policies, focusing on energy efficiency and technological upgrades[81]. - The company is addressing the challenges of using complex and degraded PCR recycled plastics through innovative formulations[101]. Governance and Management - The board of directors consists of 11 members, including 4 independent directors, complying with legal and regulatory requirements[176]. - The company has a supervisory board with 3 members, including 1 employee representative, ensuring oversight of the board and management[178]. - The company has implemented a transparent performance evaluation and incentive mechanism for senior management, ensuring compliance with legal regulations[179]. - The company maintains financial independence with a dedicated finance department and independent accounting system, ensuring autonomous financial decision-making[187]. - The management team has a clear strategic vision for sustainable development, leveraging extensive industry experience and a robust operational capability[58]. Financial Management and Investments - The company has a self-funded construction rate of 95% for its projects, indicating strong financial management[120]. - The company is committed to maintaining a high utilization rate of its raised funds, with 0% reported as idle[125]. - The total amount of raised funds is RMB 41.7 million, with no changes reported in the investment projects during the reporting period[131]. - The company has made strategic investments in new projects, although specific details on the projects were not provided[113]. - The company is focusing on technological advancements in new materials, which is expected to drive future growth[198]. Customer and Market Insights - The company has over 3,000 customers globally, with a marketing network covering more than 20 countries and regions, enhancing its brand influence and reputation[67]. - User data indicates that the production capacity for hydrogen reached 2 million m³/a, highlighting the company's focus on sustainable materials[135]. - User data showed an increase in active users by 20% year-on-year, reaching 500,000 users by the end of 2022[165]. - The company plans to launch three new products in 2023, targeting a market expansion of 25% in the new segments[164]. Future Outlook - Future guidance indicates a continued upward trend in revenue and profitability, driven by strategic investments and market expansion efforts[136]. - The company plans to enhance its digital marketing efforts, aiming for a 50% increase in online sales channels by the end of 2023[174]. - The company aims to enhance its antioxidant capacity utilization and implement technological upgrades across production bases in 2023[144]. - The company is committed to achieving the first annual profit for the life sciences division by 2023, with plans for industrial-scale production of key products[152].

证券代码：300596 证券简称：利安隆 公告编号：2023-031 天津利安隆新材料股份有限公司 关于举行 2022 年度网上业绩说明会的公告 天津利安隆新材料股份有限公司 董事会 出席本次说明会的人员有：公司董事长兼总裁李海平先生；董事、副总裁孙 春光先生；董事、副总裁、财务总监兼董事会秘书谢金桃女士；独立董事何勇军 先生。 为充分尊重投资者、提升交流的针对性，现就公司 2022 年度网上业绩说明 会提前向投资者公开征集问题，广泛听取投资者的意见和建议。投资者可于 2023 年 4 月 12 日（星期三）15:00 前访问 http://ir.p5w.net/zj/，或扫描下方二维 码，进入问题征集专题页面。公司将在 2022 年度业绩说明会上，对投资者普遍 关注的问题进行回答。 欢迎广大投资者积极参与本次网上说明会。 特此公告。 （问题征集专题页面二维码） 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 天津利安隆新材料股份有限公司（以下简称"公司"）于 2023 年 4 月 7 日在 中国证监会指定的创业板信息披露网站巨潮资讯网（www.cninfo. ...

股票代码：300596 股票简称：利安隆 记录编号：2017-002 天津利安隆新材料股份有限公司 投资者调研纪要 一、 参加调研情况 1. 调研时间：2017 年 6 月 8 日上午 9:30-11:30 2. 调研地点：天津市华苑产业区榕苑路 15 号 7-A-7 公司会议室 3. 来访单位：浙商证券、国金证券 4. 接待人员：董事会秘书： 谢金桃 女士 证券事务代表：刘 佳 女士 二、 公司董事会秘书介绍公司基本情况 1、公司简介 公司是国内抗氧化剂与光稳定剂生产的龙头企业。创业团队来自于高校， 公司从 1994 年开始抗老化助剂产品的研发，多年来专注于这个领域。公司目 前具有 8200 吨抗氧化剂与 3000 吨光稳定剂的设计产能，产品应用于塑料、 橡胶、化纤、涂料以及胶黏剂等多个高分子材料领域。2003 年，公司在天津 滨海新区建立生产基地，并在天津大学设立研发中心；2008 年设立欧洲子公 司，至此开始打造自己的全球营销网络建设；2011 年在宁夏中卫建设大型生 产基地，扩大光稳定剂产能，并设立应用技术工程技术中心；2012 年设立美 国子公司、香港子公司，完善全球营销网络建设；2017 年 1 ...

股票代码：300596 股票简称：利安隆 记录编号：2017-001 天津利安隆新材料股份有限公司 投资者调研纪要 一、 参加调研情况 1. 调研时间：2017 年 5 月 24 日下午 14:00-17:00 2. 调研地点：天津市华苑产业园智慧山艺术中心•滨海印吧 3. 来访单位： 东吴证券、国信证券、浙商保险、光大证券、新华基金、太平洋证券、 华创证券、中信建投、兴业证券、国联安基金、申万宏源研究、中泰证 券 4. 接待人员： 董 事 长： 李海平 先生 董事会秘书： 谢金桃 女士 证券事务代表：刘 佳 女士 二、 公司董事长李海平先生介绍公司基本情况 (一) 公司产品及行业介绍 1. 抗老化助剂业务应用广泛、市场空间巨大 包括塑料、橡胶、涂料、化纤、胶黏剂等所有的高分子材料都需要使用抗 老化助剂，以对抗高分子材料和氧接触或受到紫外线伤害而老化，"阳光之下、 空气之中"几乎概莫例外。因此，公司产品市场非常广泛。 2. 材料的改性技术，在高分子材料产业链中是核心技术。公司的主营业务 是高分子材料的抗老化技术领域，是材料改性的核心技术。 抗老化助剂防止高分子材料降解、老化，抗老化助剂通过应用在改性材料 上， ...

证券代码：300596 证券简称：利安隆 记录编号：2019-003 天津利安隆新材料股份有限公司 投资者调研会议纪要 一、 参加调研情况 调研时间：2019 年 10 月 25 日下午 13:30-17:30 调研地点：利安隆凯亚（河北）新材料有限公司 来访单位：泰康资产、华商基金、鹏华基金、汉和资本、安信证券、英大 资管、煜德投资、泓德基金、广发证券、新华基金、新华养老、新华资产、上 投摩根、承周资产、滇商资本、东兴证券、方正富邦、方正证券、丰和资本、 光大证券、国金证券、国泰君安、华西证券、华安基金、华泰证券、华夏基金、 建信基金、建信养老基金、千合基金、国寿资产、融通基金、申港证券、申万 宏源、太和投资、太平洋证券、泰达基金、天风证券、相聚资本、大家保险资 管、兴业证券、阳光保险、易方达基金、翼虎投资、长江证券、招商证券、中 欧基金、中银基金、中再保险、泓澄投资、华宝基金。 来访战略合作客户：万华化学、金发科技、华峰氨纶、台湾欣晃、新升实 业、东辰瑞森、晋江科技。 接待人员：公司董事长李海平先生；利安隆凯亚（河北）新材料有限公司 总经理韩伯睿先生；公司董事、营销中心中国区总监毕红艳女士；公司副总经 理 ...

证券代码：300596 证券简称：利安隆 记录编号：2019-001 天津利安隆新材料股份有限公司 投资者调研会议纪要 一、 参加调研情况 调研时间：2019 年 6 月 27 日下午 13:30-16:30 调研地点：浙江常山科润新材料有限公司 来访单位：华商基金、泰康资产、招商证券、新时代证券、东方财富证券、 金元顺安基金、万丰友方、滇商资本、国投瑞银基金、鑫富越资产、中泰和盛、 颐和银丰投资、申万宏源、西南证券、华创证券、天风证券、国金证券、杭州 睿银资产、汉和资产、颜大鹏、中欧基金、财通证券、中银国际证券、东北证 券、宁波若汐投资、国泰君安、海通证券等。 接待人员： 公司董事、副总经理、浙江常山科润新材料有限公司董事长：毕作鹏先生； 公司董事、财务总监：谢金桃女士；公司副总经理兼董事会秘书：张春平先生； 浙江常山科润新材料有限公司总经理：何火雷先生；公司证券事务代表刘佳女 士；公司投资者关系经理：蒋少华女士。 二、公司证券事务代表介绍公司相关情况 1、公司基本情况 利安隆是全球领先的高分子材料抗老化助剂产品和技术供应商，主要产品 有抗氧化剂、光稳定剂和整体解决方案产品 U-pack。公司是国家级高新技 ...

证券代码：300596 证券简称：利安隆 记录编号：2019-002 天津利安隆新材料股份有限公司 投资者调研会议纪要 一、 参加调研情况 调研时间：2019 年 8 月 8 日下午 14:30-17:00 调研地点：天津利安隆新材料股份有限公司天津汉沽基地 来访单位：天津市部分券商营业部负责人、个人投资者、天津市证监局、 天津上市公司协会、天津证券业协会、部分资本市场媒体。 接待人员：公司董事、总经理孙春光先生；公司董事、财务总监谢金桃女 士；公司副总经理、董事会秘书张春平先生；公司汉沽基地总经理管波先生； 公司证券事务代表刘佳女士；公司投资者关系经理蒋少华女士。 二、参观汉沽基地厂区 由利安隆汉沽基地总经理带领来访人员参观了汉沽基地车间、仓储、研发 中心、应急指挥中心、产品展厅，并做了详细介绍和现场答疑。 三、介绍公司相关情况 | --- | |------------------------------------------------------------------------| | | | 利安隆是全球领先的高分子材料抗老化助剂产品和技术供应商，主要产品 | | 有抗氧化剂、光稳定剂和整体解决 ...

证券代码：300596 证券简称：利安隆 记录编号：2018-001 天津利安隆新材料股份有限公司 投资者调研会议纪要 一、 参加调研情况 调研时间：2018 年 6 月 21 日上午 9:30-11:30 调研地点：天津华苑产业园区开华道 20 号 F 座 19 层公司培训室 | --- | |------------------------------------------------------------------------| | | | 来访单位：招商证券、广发证券、东兴证券、华泰证券、鹏华基金、光大 | | 证券、嘉实基金、广发基金、富果投资、泰康资产、百朋嘉业资管、新时代证 | | 券、国盛证券、东方证券、华创证券、诺安基金、中融基金、天风证券、上投 | | 摩根、源乐晟资管、太平洋证券、民生证券、鹿鼎资本、汉和汉华、国元证券、 | | 中融基金、煜德投资、九鼎基金、海通证券、华商基金、申万宏源证券、光大 | | 永明资产、安信证券、红塔证券、长城国瑞证券、国海证券、国泰君安证券、 | | 华泰柏瑞基金、财通基金 | 接待人员：董事、财务总监 谢金桃 女士，董事会秘书 张春平先生，证券事 ...